Carsil, 35 mg 180 pcs

Carsil is a hepatoprotector.

Derived from the plant Silybum marianum.

It has hepatoprotective and antioxidant effect.

Therapeutic effect is due to the effect on the metabolism of hepatocytes.

Activates the synthesis of proteins and enzymes in hepatocytes, stabilizing effect on the membrane of hepatocytes, inhibits the penetration of toxins into the liver cells, inhibits dystrophic processes, potentiates regenerative processes in the liver.

Indications

As part of complex therapy:

toxic liver damage;
conditions after acute hepatitis;
chronic hepatitis of non-viral etiology;
liver steatosis (non-alcoholic and alcoholic);
cirrhosis;
prevention of liver damage due to prolonged use of medications, alcohol, chronic intoxication (including occupational).

Pharmacological effect

Karsil is a hepatoprotector.

Derived from the Silybum marianum plant.

Has hepatoprotective and antioxidant effects.

The therapeutic effect is due to the effect on the metabolism of hepatocytes.

Activates the synthesis of proteins and enzymes in hepatocytes, has a stabilizing effect on the hepatocyte membrane, inhibits the penetration of toxins into liver cells, inhibits degenerative processes, and potentiates regenerative processes in the liver.

Special instructions

Due to the possible estrogen-like effect of silymarin, it should be used with caution in patients with hormonal disorders (endometriosis, uterine fibroids, carcinoma of the breast, ovary, uterus and prostate). In these cases, consultation with a specialist is necessary.

The drug is not used for the treatment of acute intoxication.

The drug contains wheat starch as an excipient.

Wheat starch may contain gluten, but in small quantities, and is therefore considered safe for patients with celiac disease. Patients with a wheat allergy (but not celiac disease) should not take this drug.

The drug contains sucrose as an excipient. Patients with rare hereditary fructose intolerance, galactose intolerance, glucose-galactose malabsorption or sucrose-isomaltase deficiency should not take the drug.

Carsil forte caps contains 90 mg. No. 30 excipients of the drug include lactose. Patients with rare hereditary galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome should not take the drug. Patients with intolerance to some other sugars should consult a doctor.

Active ingredient

Milk thistle fruit extract

Composition

1 tablet contains:

Active substance:

silymarin 35 mg.

Contraindications

Hypersensitivity to the active or any of the excipients of the drug Carsil Forte;
lactase deficiency, galactosemia or glucose/galactose malabsorption syndrome (presence of lactose in the drug);
celiac disease (gluten enteropathy) – the presence of wheat starch in the composition of the drug;
children under 12 years of age.

With caution: patients with hormonal disorders (endometriosis, uterine fibroids, breast, ovarian and uterine carcinoma, prostate carcinoma) – an estrogen-like effect of silymarin may occur.

Overdose

There are no reports of cases of overdose.

If you accidentally take a dose several times higher than the therapeutic dose, it is necessary to induce vomiting, rinse the stomach, take activated charcoal and, if necessary, carry out symptomatic treatment.

Storage conditions

Store in a dry place, protected from light, at a temperature not exceeding 25 °C.

Shelf life

2 years

Manufacturer

Sopharma JSC, Bulgaria